← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Alphamed, Inc
Wrentham, MA
$2,253,587
Total funding
11
Grants
Funding over time
peak $618.2K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,253,587 · 11
By mechanism
R44$754,469 · 1
R41$548,342 · 5
R42$500,726 · 1
R43$300,050 · 3
N43$150,000 · 1
Investigators at Alphamed, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Production and use of Pb-203 for cancer therapy research$397,597
R44 · FY2008 · CA
Production and use of Pb-203 for cancer therapy research$356,872
R44 · FY2009 · CA
Melanoma Therapy via peptide targeted alpha-radiation$252,667
R42 · FY2004 · CA
Melanoma Therapy via peptide targeted alpha-radiation$248,059
R42 · FY2002 · CA
BIOMEDICAL (BASIC)$150,000
N43 · FY2009 · CA
Targeting alpha particle-emitting radionuclides to the nuclei of cancer cells$115,953
R41 · FY2007 · CA
A Pb-212 Generator Using Resistant Substrate and Rn Cold Trapping$111,339
R41 · FY2009 · CA
Processing Ac-227 sources for lead-212 and radium-223 required by cancer research$111,300
R41 · FY2007 · CA
High-Energy Imaging in Support of Radionuclide Therapy$109,750
R41 · FY2006 · CA
Production and use of Pb-203 for cancer therapy research$100,038
R43 · FY2005 · CA
Pb-212 generator for cancer therapy$100,012
R43 · FY2004 · CA
Production and use of Cu-67 in cancer therapy research$100,000
R43 · FY2005 · CA
Production of High Specific Activity Lutetium-177$100,000
R41 · FY2005 · CA